Sanofi (SNY) Treasury Shares (2009 - 2025)
Sanofi (SNY) posted Treasury Shares of -$3.8 billion for Q1 2025, down 1076.34% sequentially from -$322.7 million in Q4 2024, and down 1057.11% YoY from $396.6 million in Q1 2024.
Sanofi (SNY) Treasury Shares (2009 - 2025) Analysis & Trends
Sanofi has reported Treasury Shares for 17 years, with the latest figure at -$3.8 billion in Q1 2025.
- Quarterly Treasury Shares fell 1057.11% year-over-year to -$3.8 billion in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$3.8 billion (down 1057.11% YoY) and the FY2024 annual result came in at -$322.7 million, up 49.69% from the prior year.
- Treasury Shares fell to -$3.8 billion in Q1 2025 per SNY's latest filing, from -$322.7 million in the prior quarter.
- Over five years, Treasury Shares peaked at -$168.6 million in Q2 2021 and troughed at -$980.1 million in Q4 2020.
- A 5-year average of -$470.3 million and a median of -$397.6 million in 2020 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2025: Treasury Shares soared 57.63% in 2021, then slumped 1057.11% in 2025.
- Over 5 years, Treasury Shares stood at -$437.0 million in 2021, then slipped by 16.03% to -$507.1 million in 2022, then decreased by 25.83% to -$638.0 million in 2023, then soared by 49.42% to -$322.7 million in 2024, then sank by 1076.34% to -$3.8 billion in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered -$3.8 billion, -$322.7 million, and -$331.7 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 75.86 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 1.11 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 49.00 Mn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | - |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 115.19 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -3.80 Bn |
| Mar 31, 2025 | -3.80 Bn |
| Dec 31, 2024 | -322.72 Mn |
| Dec 31, 2024 | -322.72 Mn |
| Sep 30, 2024 | -331.66 Mn |
| Sep 30, 2024 | -331.66 Mn |
| Jun 30, 2024 | -325.22 Mn |
| Jun 30, 2024 | -325.22 Mn |
| Mar 31, 2024 | -328.08 Mn |
| Mar 31, 2024 | -328.08 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Dec 31, 2023 | -638.03 Mn |
| Sep 30, 2023 | -395.16 Mn |
| Sep 30, 2023 | -395.16 Mn |
| Jun 30, 2023 | -395.28 Mn |
| Jun 30, 2023 | -395.28 Mn |
| Mar 31, 2023 | -389.62 Mn |
| Mar 31, 2023 | -389.62 Mn |